131 related articles for article (PubMed ID: 25851702)
1. Cost-Effectiveness of Long-Term Every Three-Year Versus Annual Postoperative Surveillance for Low-Risk Papillary Thyroid Cancer.
Wu JX; Beni CE; Zanocco KA; Sturgeon C; Yeh MW
Thyroid; 2015 Jul; 25(7):797-803. PubMed ID: 25851702
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of papillary thyroid cancer surveillance.
Wang LY; Roman BR; Migliacci JC; Palmer FL; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
Cancer; 2015 Dec; 121(23):4132-40. PubMed ID: 26280253
[TBL] [Abstract][Full Text] [Related]
3. Routine prophylactic central neck dissection for low-risk papillary thyroid cancer: a cost-effectiveness analysis.
Zanocco K; Elaraj D; Sturgeon C
Surgery; 2013 Dec; 154(6):1148-55; discussion 1154-5. PubMed ID: 24383082
[TBL] [Abstract][Full Text] [Related]
4. Routine prophylactic central neck dissection for low-risk papillary thyroid cancer is not cost-effective.
Garcia A; Palmer BJ; Parks NA; Liu TH
Clin Endocrinol (Oxf); 2014 Nov; 81(5):754-61. PubMed ID: 24862564
[TBL] [Abstract][Full Text] [Related]
5. Lobectomy is a more Cost-Effective Option than Total Thyroidectomy for 1 to 4 cm Papillary Thyroid Carcinoma that do not Possess Clinically Recognizable High-Risk Features.
Lang BH; Wong CKH
Ann Surg Oncol; 2016 Oct; 23(11):3641-3652. PubMed ID: 27221359
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer.
Venkatesh S; Pasternak JD; Beninato T; Drake FT; Kluijfhout WP; Liu C; Gosnell JE; Shen WT; Clark OH; Duh QY; Suh I
Surgery; 2017 Jan; 161(1):116-126. PubMed ID: 27839930
[TBL] [Abstract][Full Text] [Related]
7. Thyroid lobectomy as a cost-effective approach in low-risk papillary thyroid cancer versus active surveillance.
Youssef MR; Attia AS; Omar M; Aboueisha M; Freeman MN; Shama M; Kandil E
Surgery; 2022 Jan; 171(1):190-196. PubMed ID: 34384606
[TBL] [Abstract][Full Text] [Related]
8. A cost-utility analysis for prophylactic central neck dissection in clinically nodal-negative papillary thyroid carcinoma.
Wong CK; Lang BH
Ann Surg Oncol; 2014 Mar; 21(3):767-77. PubMed ID: 24276639
[TBL] [Abstract][Full Text] [Related]
9. Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
Pradhan MC; Kazaure HS; Wang F; Zambeli-Ljepovic A; Perkins JM; Stang MT; Scheri RP
J Surg Res; 2021 Aug; 264():37-44. PubMed ID: 33765509
[TBL] [Abstract][Full Text] [Related]
10. Postoperative stimulated thyroglobulin of less than 1 ng/ml as a criterion to spare low-risk patients with papillary thyroid cancer from radioactive iodine ablation.
Rosario PW; Mineiro Filho AF; Prates BS; Silva LC; Calsolari MR
Thyroid; 2012 Nov; 22(11):1140-3. PubMed ID: 23050786
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of routine ultrasonographic surveillance of patients with low-risk papillary carcinoma of the thyroid.
Wang LY; Roman BR; Palmer FL; Tuttle RM; Shaha AR; Shah JP; Patel SG; Ganly I
Surgery; 2016 May; 159(5):1390-5. PubMed ID: 26747227
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis of thyroid lobectomy and intraoperative frozen section versus total thyroidectomy in patients with a cytologic diagnosis of "suspicious for papillary thyroid cancer".
Leiker AJ; Yen TW; Cheung K; Evans DB; Wang TS
Surgery; 2013 Dec; 154(6):1307-13; discussion 1313-4. PubMed ID: 24238049
[TBL] [Abstract][Full Text] [Related]
13. Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients.
Lamartina L; Montesano T; Trulli F; Attard M; Torlontano M; Bruno R; Meringolo D; Monzani F; Tumino S; Ronga G; Maranghi M; Biffoni M; Filetti S; Durante C
Endocrine; 2016 Nov; 54(2):467-475. PubMed ID: 26668060
[TBL] [Abstract][Full Text] [Related]
14. Disease outcomes and nodal recurrence in patients with papillary thyroid cancer and lateral neck nodal metastases.
O'Neill CJ; Coorough N; Lee JC; Clements J; Delbridge LW; Sippel R; Sywak MS; Chen H; Sidhu SB
ANZ J Surg; 2014 Apr; 84(4):240-4. PubMed ID: 23316684
[TBL] [Abstract][Full Text] [Related]
15. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
16. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
[TBL] [Abstract][Full Text] [Related]
17. Is There Justification for Total Thyroidectomy in Low-Risk Papillary Thyroid Carcinoma? A Decision-Analysis Model.
Stern S; Hilly O; Horowitz E; Leshno M; Feinmesser R
World J Surg; 2015 Nov; 39(11):2707-17. PubMed ID: 26243560
[TBL] [Abstract][Full Text] [Related]
18. Patients with Papillary Thyroid Carcinoma at Intermediate Risk of Recurrence According to American Thyroid Association Criteria Can Be Reclassified as Low Risk When the Postoperative Thyroglobulin Is Low.
Rosario PW; Furtado Mde S; Mourão GF; Calsolari MR
Thyroid; 2015 Nov; 25(11):1243-8. PubMed ID: 26359309
[TBL] [Abstract][Full Text] [Related]
19. Papillary Thyroid Carcinoma Recurrence: Low Yield of Neck Ultrasound With an Undetectable Serum Thyroglobulin Level.
Epstein S; McEachern R; Khot R; Padia S; Patrie JT; Itri JN
J Ultrasound Med; 2018 Oct; 37(10):2325-2331. PubMed ID: 29498418
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness Analysis of Routine Magnetic Resonance Imaging in the Follow-Up of Patients With Nasopharyngeal Carcinoma After Intensity Modulated Radiation Therapy.
Zhou GQ; Wu CF; Zhang J; Mao YP; Tang LL; Chen L; Guo R; Ma J; Sun Y
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1382-1391. PubMed ID: 29804816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
